Screener
TBXU vs LABD
Direxion Daily Biotech Top 5 Bull 2X ETF vs Direxion Daily S&P Biotech Bear 3X Shares
Key differences
- TBXU costs 0.09% less per year.
- LABD is significantly larger than TBXU — larger funds tend to be more liquid and less likely to close.
- TBXU follows a leveraged strategy; LABD uses inverse.
- LABD has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| TBXU | LABD | |
|---|---|---|
| Annual cost (TER) | 0.98% | 1.07% |
| Fund size (AUM) | $3M | $69M |
| Since | 2025 | 2015 |
| Dividend yield | — | 6.38% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | leveraged | inverse |
| CAGR 1Y | N/A | -82.9% |
| CAGR 3Y | N/A | -50.8% |
| CAGR 5Y | N/A | -42.0% |
| Sharpe 3Y | N/A | -0.52 |
| Volatility 1Y | — | 74.72% |
| Max drawdown | -25.36% | -99.98% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to TBXU and LABD
Explore further